Introduction
Epilepsies are some of the most common chronic neurological conditions of childhood, with an estimated prevalence of 4.3 per 1000 children [1, 2] . This equates to an estimated 65,000 children and young people with active epilepsy living in the UK. An average 57 children and young people aged <18 years die each year in the UK with epilepsy recorded as the underlying cause of death, and a further 55 registered deaths cite epilepsy as an underlying condition on the death certificate (Ruth Gilbert, Pia Hardelid, personal communication). Epilepsy-related deaths may occur as a direct result of the seizure (including convulsive status epilepticus), as a consequence of treatment given for the epilepsy, as an accident (including drowning), as sudden unexpected death in epilepsy (SUDEP), or may be related to an associated underlying neurological problem or arise from an unrelated cause.
Some epilepsy-related deaths are likely to be unavoidable, but others may relate to deficiencies in the care provided to children and their families. A previous national audit in 2002 concluded that 59% of epilepsy-related child deaths were potentially avoidable [3] . This was particularly related to limited access to specialist paediatric neurology expertise and the use of potentially inappropriate anti-epileptic medication. Since the publication of this National Sentinel Audit, a number of initiatives have focussed on the improvement of care of people of all ages with epilepsies [4] , including the publication of national guidelines for the management of epilepsies [5] [6] [7] . A recent review of services for children with epilepsies [4] identified a number of improvements in overall care of these children, findings echoed in the 2012 national 'Epilepsy 12' audit [8] . However, there has been no more recent national review of epilepsy deaths, and recent high-profile cases suggest that poor quality of care may still be contributing to the deaths of some children with epilepsies [9] .
As part of a national review of the quality of healthcare for children and young people with epilepsies, we sought to evaluate the case records of all reported deaths in children and young people with epilepsies across the UK between June 2012 and March 2013 [10] . The aim of the review was to ascertain any demographic, clinical, organisational or management factors associated with these deaths, and to determine the extent to which any of these deaths may have been associated with divergence from nationally agreed best practice. It was anticipated that any identified deficiencies in care, as well as examples of good practice, could be used to promote good quality care and to make recommendations for the provision of services to children and young people with epilepsies.
Methods
The review used a mixed-methods approach, incorporating questionnaire-based demographic and clinical data, and a case notes review combining an explicit criterion-based assessment of clinical care with a more in-depth holistic review [11] . The review included any child or young person aged from 1 year and up to their eighteenth birthday with a prior diagnosis of epilepsy who died of any cause (Box 1). The time period for the review was 1 June 2012 to 31 March 2013. The time period for notification was limited by the requirements of the commissioning bodies.
Currently in the UK there is no national registry of epilepsy, although a voluntary epilepsy deaths register was established in 2013 by SUDEP Action (www.sudep.org/article/epilepsydeaths-register). However, national guidance specifies that 'the diagnosis of epilepsy in children and young people should be established by a specialist paediatrician with training and expertise in epilepsy' [5] . While there may be small numbers of older young people managed solely by general practitioners or adult neurology services, in practice nearly all, and certainly all complex cases are managed by paediatricians. All consultant paediatricians across the UK were e-mailed on a monthly basis and asked to notify the team of any cases they had seen in the previous month. For each reported case, the consultant was asked to complete a secure web-based questionnaire providing demographic and clinical details. In order to maximise case ascertainment the study was advertised widely so others could notify cases, including intensive care units and child death overview panels, and a data-sharing agreement was set up with PICANet, a national paediatric intensive care audit network.
For each notified case, the case notes were requested from the child's first seizure through to the death, incorporating records from primary, secondary and tertiary care settings. Each set of case notes was reviewed by a pair of case assessors comprised of a paediatric nurse and a paediatrician who were actively involved in the care of children with epilepsies, and had undergone training in epilepsy care. None of the case assessors had been involved with the care of the children prior to, or following their death. The case assessors were trained in case notes review methodology and were supported by the research team, with regular briefing meetings and the opportunity to discuss any queries that arose from their review. The case assessment tool was structured around six phases of care (initial diagnosis and management; ongoing management; pre-hospital care; emergency department care; intensive or high dependency care; and care of the child and family around and following the death). The tool included a criterion-based assessment using recognised clinical standards [5, 7, 12, 13] , and a structured implicit review in which the case assessors were asked to rate the quality of care in each phase and to comment on any learning points and identified avoidable or remediable factors; they were also tasked with the identification of elements of good clinical practice and care. Details of the case assessment tools and their development are provided in the full CHR-UK report and in Appendix 1 [10] . Case assessors were required to classify the cause of death, according to a structured proforma (Appendix 2) and each case was reviewed by the lead researcher (PS) to confirm the classification of the death.
Ethical advice on the review was sought from the National Research Ethics Service. As a national service evaluation, the review was granted National Information Governance Board 251 approval to collect patient identifiable data without consent, along with equivalent approvals from the Scotland Caldicott Guardian and the Northern Ireland Privacy Advisory Committee. All patientidentifiable data were removed from the database prior to analysis by the research team.
Results
A total of 46 deaths in children with epilepsies were notified to the study. Hospital and community case notes were obtained for detailed review on 33 children. In spite of repeated attempts, case notes for the remaining 13 children were not provided by the hospital or community health providers. Details of the 46 children are shown in Table 1 . The majority (94%) were known to have associated co-morbid conditions, including developmental impairments, most of which were severe and required multi-disciplinary care. Thirty-one children (67%) had a recognised cause for their epilepsy, of which the most common were identified genetic disorders [10] , hypoxic-ischaemic neonatal brain injury [7] , and cerebral malformations [6] . Eight children (17%) had an identified epilepsy syndrome, including West, Dravet, a progressive myoclonic epilepsy, Lennox Gastaut, epilepsy with generalised tonicclonic seizures on awakening, and epilepsy with myoclonic absences.
The majority of children (29/46, 63%) were at home when they died or at the start of the incident that led to their death; 23 of these were transferred to hospital, including seven who received intensive or high dependency care for a prolonged seizure prior to their death. Five children were already in a hospice at the time of their death and a further four were transferred to a hospice for end of life care. Sixteen children (35%) were experiencing at least weekly seizures prior to their death, although these rarely necessitated a hospital attendance. Seven children (15%) had been admitted to hospital with a prolonged seizure (usually tonicclonic) in the previous 12 months. In 28 (85%) of the 33 children whose case notes were reviewed, there was evidence that a paediatric neurologist or paediatrician with expertise in epilepsy had been involved in the initial diagnosis or ongoing follow-up of the child. In 14 cases (42%) there was evidence of previous involvement of an epilepsy specialist nurse. In two children, there was evidence of inappropriate medication use in the 6 months prior to the child's death. In one, a child with poorly controlled absence and generalised tonic-clonic seizures, sodium valproate had been increased to a dose higher than that recommended in the British National Formulary for Children (BNFc) before trying a second anti-epileptic drug. This child died of a complication of his underlying neurodisability. The second child, who died as a SUDEP, was receiving four anti-epileptic drugs, which had been frequently changed over the past few months and there was a lack of clarity over which clinician (consultant paediatrician or paediatric neurologist) was taking overall responsibility for the medication reviews.
The cause of death as determined by a detailed and careful review of the clinical notes is given in Table 2 . In five cases there was insufficient information in the case notes or questionnaire to be able to classify the death. The majority of children died of causes other than their epilepsy. Most deaths were of children with complex co-morbidities who died of respiratory infections or respiratory failure directly associated with their underlying disability, most notably severe quadriplegic cerebral palsy secondary to prematurity. For many of these children the death was anticipated and an end of life care plan or other palliative care measures had been put in place prior to death. The two children who died of unrelated causes (one chronic medical condition and one acute surgical condition) also had recognised developmental impairments. There was one child for whom a recognised complication of their anti-epileptic treatment was identified and considered a possible cause of death (intracranial haemorrhage presumed secondary to marked thrombocytopaenia). The seven children who died in an episode of convulsive status epilepticus had suffered a cardiac or respiratory arrest during the seizure and either could not be resuscitated or died from subsequent multiorgan failure. Three of these seven children had been experiencing at least weekly tonic or tonic-clonic seizures, but four were considered to be well-controlled with a tonic-clonic seizure frequency of less than one a month and no hospital admission within the preceding 12 months.
Of the seven children classified as SUDEP, two satisfied the criteria for definite SUDEP (i.e. autopsy reports were available in the notes) and five for probable SUDEP [14] . All seven were found in their beds by their parent or carers, following a period of 4 (14) 3 (13) Concurrent disability
43 (94) 32 (97) a Percentages based on the number for whom data were available. b Based on the index of multiple deprivation for the postcode of the child's residence. Table 2 Cause of death.
Classification Number (%) Comments
Death from a cause unrelated to the epilepsy 2 (4) Two children died of conditions unrelated to their epilepsy, one surgical, one medical. Both children were also reported to have associated developmental impairments, but these were not related to the cause of death. Death from a co-morbidity associated with the epilepsy 24 (52) Mostly these were children with complex co-morbidities who died of respiratory infections/ respiratory failure in association with their co-morbidities. Six children had cerebral palsy and died of pneumonia or respiratory failure. Ten had other defined neurological conditions including Batten's disease, lissencephaly, Leigh's disease, Rett syndrome, Alpers syndrome and leukodystrophy; these children died as a result of pneumonia, sepsis or multi-organ failure. The remaining children had unspecified complex neurodisability and died either of pneumonia/sepsis, or from a cardiac arrest. Death as a consequence of treatment given for epilepsy 1 (2) One child died of a cause secondary to low platelets, a recognized side effect of the child's prescribed anti-epileptic drugs. This was therefore classified as a possible consequence of a treatment given for epilepsy. Trauma associated with a seizure 0 (0) There were no children in whom the clinical questionnaire or review of the clinical records indicated that the child had died as a consequence of trauma associated with a seizure. Death secondary to status epilepticus unobserved sleep. Five of the seven had recognised developmental impairments. Five children were receiving at least two antiepileptic drugs, had been experiencing daily seizures, and had required at least one hospital admission in the preceding 12 months. The remaining two children were receiving a single antiepileptic drug and were not reported to have experienced frequent seizures in the months prior to their death. The paired case-assessors determined that 8/33 deaths (24%) were preventable according to the definition used by English Child Death Overview Panels: 'A death is considered preventable if the assessor has identified one or more factors, in any domain, which may have contributed to the death of the child and which, by means of locally or nationally achievable interventions, could be modified to reduce the risk of future child deaths' [15] . Factors that were considered to have contributed to these deaths related to fragmentation of care, appropriate support for families in responding to emergencies, and hospital responses to the acutely unwell child, including those presenting with convulsive status epilepticus ( Table 3) .
In 16 cases (48%), the case-assessors identified gaps in the quality of care provided where it had fallen short of current best practice in one or more significant areas, although the gaps were not necessarily considered to have contributed to the child's death (Table 4 ). These included cases where an appropriate specialist had not been involved in the initial diagnosis; anti-epileptic drugs had not been administered according to agreed protocols; there was no clear emergency care plan; or where there was poor communication between professionals and family. In 11 cases, there were gaps in the quality of care in more than one area. Further evidence of gaps in the quality of care was provided in relation to the individual standards of care measured. Compliance with these is documented in Table 5 .
Eighteen children had a recognised life-limiting condition. In 17 (94%), there was documented evidence that the child's prognosis had been discussed with the family, and in 12 (67%) there was a documented and agreed end of life care plan.
The poor quality of record-keeping following the child's death meant that, in nearly all cases, it was difficult to determine what actions had taken place in relation to any investigation or classification of the cause of death, onward referral, family support or case review. In 19 (58%) children, there was evidence that an appropriately trained clinician had taken a clinical history, examined the child, and arranged for appropriate investigations either before or after the child's death. Seventeen cases had been referred to a coroner or procurator fiscal. In five cases there was evidence that an autopsy had been carried out, but there was rarely any record of the outcome of the autopsy in the clinical notes. In four cases there was documented evidence of a case discussion or child death review following the death. In 19 (58%) cases there was evidence that the family had been offered support from healthcare professionals following the death, through letters to the parents, home visits, follow up appointments, or a combination of all three.
Discussion
This review is the first UK-wide review of children's epilepsy deaths since the 2002 National Sentinel Audit [3] and follows considerable national initiatives to improve the quality of care for children with epilepsies, including the publication of national guidelines for epilepsy care [4] [5] [6] [7] . As a nationally commissioned review, we were able to ensure full coverage from all four devolved nations of the UK. In spite of our efforts to ensure comprehensive reporting, one of the weaknesses of the study was in relying primarily on paediatricians as the sole source of notification. The numbers reported were lower than expected over this time period. Nevertheless, the findings were clinically relevant, and it is likely that similar learning would have emerged had more cases been reported to the study. Robust methods that combined explicit criterion-based assessments with a structured holistic review highlighted examples of good practice but also clearly identified factors that could further improve the care of children with epilepsy.
Overall, this review demonstrates an improved quality of care when compared with the findings of the National Sentinel Audit. This review has shown that children and young people with epilepsy are generally being well managed, with good, holistic and supportive care, and reflects our earlier findings on the quality of care following prolonged seizures [16] , and those of the 'Epilepsy 12 0 audit [8] .
The figure of 24% of deaths being assessed as preventable is similar to other, wider reviews of children's deaths from all causes [17] . It is considerably lower than the 59% of deaths deemed potentially avoidable in 2002 [3] . Two findings stand out in this respect: inadequate access to specialist care (consultant paediatrician or paediatric neurologist) was identified in 8/22 (36%) children in the 2002 audit, and inadequate anti-epileptic drug Table 3 Modifiable factors which may have contributed to death.
Issue
Case assessors' examples from the case review Fragmentation of care 'Child seen with a respiratory infection a week before death following a prolonged seizure. No review of AED undertaken'. 'In relation to service provision, there was no paediatrician in charge of overall care. No evidence of a hospital care plan, no plan for chest deterioration at home, i.e. with use of antibiotics. No epilepsy review for 18 months before death despite medication changes. Multiple professionals involved but no coordinator of care'. 'The care of the child lacked cohesion and appeared fragmented due to the multiple specialists involved. Although the consultant paediatrician was very involved there were aspects of care that were delivered in isolation'. Support for families 'Child had been unwell on the evening prior to admission -mother had not sought advice but phoned the ward the next day. Had not appeared to recognise that her child was very unwell. Took child to hospital on a bus rather than call ambulance'. 'The family is from overseas and have some limited English. It seems they are a hard to reach family. There were missed appointments over a long period of time'. 'The child had been seen in hospital the day before her collapse and was noted to be unwell, but it was not clear what information had been given to the family'. Hospital responses to the acutely unwell child 'There were identified delays in appropriate management of this child's status epilepticus both in the community and in the emergency department. There were long delays before the child received any benzodiazepines and before the child was seen by an anaesthetist and definitive treatment started to bring the seizures under control. During this time the child had been hypoxic and hypotensive. A focus on controlling the seizures meant that the airway, breathing and circulation had not been adequately secured'. 'The child had a cardio-respiratory arrest and was found unconscious on the general paediatric ward. There had been failure to recognise the seriousness of the child's condition at an earlier stage and despite regular monitoring'. 'There was a failure to manage status epilepticus according to NICE Guidelines, and there was no availability of anaesthetist to manage the airway and induce anaesthesia, leading to the child having a cardiac arrest'. management (inappropriate drug, inappropriately low or high doses, or no drug prescribed) in 10/22. In contrast, 85% of children in our audit had access to specialist care, and in only two was there evidence of inappropriate anti-epileptic drug management. The drug management of epilepsies is complex; there will inevitably be some situations, particularly in more complex cases, where it is appropriate to deviate from published guidelines, for example through using higher than recommended doses, or an alternative medication. We noted some cases where non-standard treatment had been used and the reasons for this clearly documented in the notes. In other cases, however, there was nothing in the notes to indicate why recommended practice had not been followed. Nevertheless, in spite of the overall improvements in the quality of care, the fact that nearly one in four deaths were judged to be preventable precludes complacency. Furthermore, even in those children whose deaths were not considered preventable, a significant proportion had identified gaps in one or more aspects of the care pathway. These primarily related to fragmentation of care in children with multiple, complex needs; communication with and support for families; and the recognition of and response to acute illness.
Similar to previous reports, the majority of children in this review had concurrent co-morbidities, highlighting that deaths are more likely in children with complex neuro-disability. The majority of these children died of co-morbidities rather than of the epilepsy. These children often have complex needs requiring multi-disciplinary health input, along with support from education and social care. With many professionals involved, it is easy for different aspects of the child's care to be fragmented, with the potential for critical elements of care to be neglected or dealt with in isolation. This was particularly noted when children were admitted to hospital with prolonged seizures where information about the admission and any changes to anti-epileptic treatment (both maintenance and emergency) was not shared with the clinicians involved in the child's ongoing care. Communication between different clinical teams, particularly across hospital and community settings is crucially important. Such communication could be aided by the use of a parent or carer-held 'epilepsy passport', such as is used in the care of people with diabetes [18] . Clear and effective coordination of care is recognised as a priority in both the NICE and SIGN national guidelines, and is supported by having a named clinician with overall responsibility for the child's care, and also by the involvement of epilepsy specialist nurses. Although there has been a limited increase in the number of epilepsy specialist nurses, this service was absent in more than half of the children.
Communication with families was highlighted as an important issue in the 2002 Sentinel Audit [3] and continued to be a very common theme in all of our deaths where there were identified failings in care. This was particularly prominent in relation to children who attended hospital with a prolonged seizure or acute illness, but were considered well enough to go home, or were discharged after a period of observation. In a number of cases there was minimal documentation of the information given to parents at discharge, including when to seek advice for prolonged seizures. In some cases there was evidence that the parents had subsequently been unsure of how or where to seek help if they were still worried. This issue has been identified in other settings, including a 2004 UK-wide review of children's deaths [19, 20] . When a child is discharged from hospital, parents need to be given very clear advice on what signs to look for that might indicate some deterioration in the child, how to respond to any concerns they might have, and where and when to seek advice.
In three of the cases in this review, there was evidence of inadequacies in responding to acute illness, including a failure to recognise or respond appropriately to convulsive status epilepticus. This has been identified elsewhere as a major contribution to healthcare-amenable mortality [19] [20] [21] [22] [23] . Clinicians in hospital and in the community need to be trained to recognise and respond to acute childhood illness, to recognise the severely unwell child, and to treat convulsive seizures appropriately and promptly. This requires careful attention to the basics of securing the airway, maintaining circulation, and prompt administration of benzodiazepines in appropriate doses through accessible routes. Prompt and appropriate management can be promoted by the use of individualised emergency care plans, which need to be prominent and accessible to all carers and professionals. While it is recognised that the risks of death are greatest in those children with complex co-morbidities and difficult to control epilepsies, it was notable that four of the seven children who died in an episode of convulsive status epilepticus had apparently well-controlled epilepsy. Parents and professionals need to be aware that prolonged seizures carry a significant risk of mortality, and therefore need to be treated promptly and adequately according to agreed national guidelines. Parents also need to be aware of the potential risks of SUDEP, particularly in those children with associated neuro-disability and with poorly controlled seizures. The risks associated with seizures need to be remembered, even in children with apparently wellcontrolled epilepsy, and are a stimulus to optimising seizure control.
The limited documentation following the child's death was of concern. This included a lack of information on any investigation into the cause of death, outcomes of any post-mortem examination, classification of the death, or support offered to the family. This limits our ability to draw definitive conclusions about the cause and circumstances of each death and of any factors that may have contributed to the death. A further limitation of the study is that we relied solely on health care records and did not approach pathology departments or coroners for their records. The reality that information following a death is rarely recorded in a child's health records is of concern as it limits the ability to understand and learn from any individual death. Following any child's death, parents need support, including information about the cause of their child's death. It is important that this is carried out in a coordinated manner and clearly documented in the child's notes. We would recommend that, for every child with epilepsy who dies, the local clinical team, including the paediatric neurologist or specialist in epilepsy, undertakes a case review, the results of which should be communicated with the local Child Death Overview Panel.
Although this was a national study, and likely to be broadly representative of all children in the UK dying with epilepsy, the overall response rate was 39%, and it was not possible to obtain full notes for case notes review on all the notified children. Drawing on the number of children's deaths with epilepsy mentioned on the death certificate, we would expect around 90-95 deaths within the 10-month period of the review. Thus our figures of 46 deaths notified and 33 reviewed should not be interpreted as representative of all epilepsy deaths, and caution should be exercised in interpreting data on the cause of death. Nevertheless, the number notified and proportion reviewed are higher than in the previous National Sentinel Audit. In spite of the relatively low response rate, the findings are important, and may well reflect the better end of any spectrum of care. It is possible that the clinicians who responded to the review were those who were more engaged in a The denominator is based on the number of children receiving care in this phase and for whom the particular standard applied; children who died in the community or did not receive emergency or intensive/high dependency care were excluded from those figures; where a particular item was deemed inappropriate for that child, the child was excluded from those figures. b Of note, in only two out of the seven cases of SUDEP was there evidence in the notes that risks including SUDEP had previously been discussed with the family.
epilepsy care, and that those cases not notified may have had poorer quality care. Every attempt was made to ensure the review itself was methodologically sound and reproducible, using a structured proforma with pre-defined explicit audit criteria, as well as a more holistic approach to review, and by using pairs of paediatrician/ specialist nurse assessors. Nevertheless, the review was dependent solely on the information recorded in the available notes, and this was subject to the interpretation of the case assessors. We were not able to seek the views of parents in this review, nor that of the clinicians involved in the children's care. However, it is our firm belief that these limitations do not invalidate the findings of this review. The aspects of poor quality care identified are unlikely to represent isolated events and highlight system issues which may continue to deny children optimal care and expose them to an increased risk of premature death.
Conclusions
This UK-wide review of deaths in children with epilepsies has identified a number of areas for improvement in the quality of care. Although there has been clear progress in the overall quality of care for these children, gaps in service provision remain, particularly in relation to fragmentation of care for children with complex needs, communication with parents and carers, and in the recognition of and response to acute illness, including convulsive status epilepticus. Fortunately, deaths from epilepsy are rare but a small number do die each year. Some of these deaths are not directly caused by the epilepsy, but are related to underlying comorbidities and may be unavoidable. Nevertheless, almost onequarter of all deaths reviewed in this national audit were considered to be preventable. The clinical care of these children needs to be carefully coordinated and supported by clear and effective communication between individual clinicians, specialist nurses and clinical teams, and with the young people and their parents and carers.
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